Tag: Prescription Drugs
Cemiplimab Studied as Neoadjuvant Therapy for Cutaneous SCC
In phase 2 study, about half of patients with resectable stage II to IV cutaneous squamous cell carcinoma had pathological complete response
Texas Judge Says ACA Cannot Require Coverage for PrEP
U.S. District Judge Reed O'Connor made the ruling Wednesday about Truvada and Descovy
Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
Most secondary end points did not support the results of the analysis for the primary end point
In Rare Move, FDA Panel Gives Support to Controversial ALS Drug in Second Review
Medication combines a dietary supplement used in traditional Chinese medicine with an existing prescription drug for liver disorders
FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
But getting the drug, known as Albrioza, approved is a rallying cause for patients, their families, and members of Congress
Bronchodilator Does Not Improve Respiratory Symptoms for Tobacco-Exposed
No reduction seen in respiratory symptoms for symptomatic, tobacco-exposed persons without formal diagnosis of COPD
SGLT2 Inhibitors Benefit Broad Range of Heart Failure Patients
Risk for cardiovascular death, hospitalization for heart failure reduced regardless of left ventricular ejection fraction
Dolutegravir Compared With Other Regimens for HIV in Pregnancy
Viral suppression at delivery less frequent with atazanavir-ritonavir, raltegravir than dolutegravir; no difference in adverse birth outcomes
Vamorolone Effective, Safe for Boys With Duchenne Muscular Dystrophy
Bone morbidities reduced, efficacy retained with vamorolone for boys with Duchenne muscular dystrophy
Ublituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
About 48 percent of participants receiving ublituximab had infusion-related reactions
